TY - JOUR
T1 - Erektil dysfunktion og metabolisk syndrom
AU - Ternov, Klara Kvorning
AU - Østergren, Peter Busch
AU - Fode, Mikkel
AU - Lund, Lars
PY - 2022/10/17
Y1 - 2022/10/17
N2 - This review covers erectile dysfunction (ED) in men with metabolic syndrome. Men suffering from metabolic syndrome, and all its components, are at increased risk of ED. Men with ED should be metabolically screened with BMI, waist circumference, blood pressure, HbA1c and lipids. Components of the metabolic syndrome should be well-controlled as first step in treating ED using lifestyle changes and pharmaceutical therapies. Symptomatic treatments include phosphodiesterase type 5 inhibitors, penile injections, intraurethral medication, vacuum pumps and penile implants.
AB - This review covers erectile dysfunction (ED) in men with metabolic syndrome. Men suffering from metabolic syndrome, and all its components, are at increased risk of ED. Men with ED should be metabolically screened with BMI, waist circumference, blood pressure, HbA1c and lipids. Components of the metabolic syndrome should be well-controlled as first step in treating ED using lifestyle changes and pharmaceutical therapies. Symptomatic treatments include phosphodiesterase type 5 inhibitors, penile injections, intraurethral medication, vacuum pumps and penile implants.
KW - Male
KW - Humans
KW - Erectile Dysfunction/drug therapy
KW - Metabolic Syndrome/complications
KW - Penile Prosthesis/adverse effects
KW - Phosphodiesterase 5 Inhibitors/therapeutic use
UR - https://ugeskriftet.dk/videnskab/erektil-dysfunktion-og-metabolisk-syndrom
M3 - Review
C2 - 36305253
VL - 184
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 42
M1 - V03220227
ER -